Publikationen von 0000-0002-5537-6692
(ORCID: 0000-0002-5537-6692)
 | Eine Stufe nach oben |
Anzahl der Einträge: 2.
2021
Deng, Shanshan, Solinas, Antonio 
und Calvisi, Diego F.
(2021)
Cabozantinib for HCC Treatment, From Clinical Back to Experimental Models.
Frontiers in Oncology 2021 (11), S. 1-12.
2019
Xu, Meng, Wang, Jingxiao, Xu, Zhong, Li, Rong, Wang, Pan, Shang, Runze, Cigliano, Antonio, Ribback, Silvia, Solinas, Antonio , Pes, Giovanni Mario , Evert, Katja, Wang, Haichuan, Song, Xinhua, Zhang, Shu, Che, Li, Pascale, Rosa Maria, Calvisi, Diego F., Liu, Qingguang und Chen, Xin
(2019)
SNAI1 promotes the cholangiocellular phenotype, but not epithelial-mesenchymal transition, in a murine hepatocellular carcinoma model.
Cancer Research 79 (21), S. 5563-5574.
Volltext nicht vorhanden.
, Pes, Giovanni Mario , Evert, Katja, Wang, Haichuan, Song, Xinhua, Zhang, Shu, Che, Li, Pascale, Rosa Maria, Calvisi, Diego F., Liu, Qingguang und Chen, Xin
(2019)
SNAI1 promotes the cholangiocellular phenotype, but not epithelial-mesenchymal transition, in a murine hepatocellular carcinoma model.
Cancer Research 79 (21), S. 5563-5574.
Volltext nicht vorhanden.